General Announcement Under Regulation 30 Of SEBI (LODR) 2015.
Filed with BSE · · 3 pages · English
Summary by 6ix AI
Emrock Corporation Limited has filed a general announcement regarding its investment in Emrock Lifescience LLP, indicating a significant contribution to its capital as a subscribing partner. This investment is part of the company's strategic initiative to enter the pharmaceutical sector. The company confirms that this transaction falls under related party transactions due to its direct involvement with the LLP.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Emrock Corporation Limited on 6ix
Earlier from Emrock
- Compliance-57 (5): intimation after the end of quarter
- Emrock Corporation Limited Press Release Sep 29 2026
- Emrock Corporation Limited Press Release Sep 28 2026
- Emrock Corporation Limited Press Release Sep 07 2026
- Emrock Corporation Limited Press Release Aug 14 2026
Later from Emrock
- Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Clarification Regarding Typographical Error In The Notice And Corrigendum To The Notice Of The Extra-Ordinary General Meeting Scheduled T
- Board Meeting Intimation for Board Meeting Intimation For Approval Of Un-Auditrd Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September,2026
- Announcement under Regulation 30 (LODR)-Allotment
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Follow Emrock into a list and get an email when it puts out news.
Follow Emrock